Advice
In the absence of a submission from the holder of the marketing authorisation.
hydroxycarbamide (Siklos®) is not recommended for use within NHS Scotland for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in paediatric and adult patients suffering from symptomatic Sickle Cell Syndrome.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHS Scotland
Download detailed advice41KB (PDF)
Medicine details
- Medicine name:
- hydroxycarbamide (Siklos)
- SMC ID:
- 582/09
- Indication:
- Prevention of recurrent painful vaso-occlusive crises
- Pharmaceutical company
- Nordic Pharma UK
- BNF chapter
- Nutrition and blood
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 12 October 2009